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The genetically determined autoimmunity in NZB/NZW F1 mice is similar to 
that observed in human systemic lupus erythematosus, and these mice, there- 
fore, provide an animal model for the study of the latter disease. The immuno- 
logical abnormalities of NZB and the hybrid NZB/NZW mice include defects in 
the induction and maintenance of tolerance to foreign host antigens (1-3), in the 
development of antibodies with specificity for nucleic acids (4, 5), erythrocytes 
(5, 6), and lymphoid cells (7, 8), in the development  of immune complex glomeru- 
lonephritis (5), and Coombs' positive hemolytic anemia (5, 6). Current notions as 
to the pathogenesis of autoimmunity  in NZB/NZW mice center on the possibility 
that these animals lose suppressor cell activity as they age, thereby allowing the 
development of forbidden clones with self antigen specificity (3, 5, 6, 9, 10). The 
data supporting these concepts are, as yet, indirect. In brief, they indicate that 
various circulating and cellular immune responses are increased in older NZB/ 
NZW mice and that this enhancement is reduced by the injection of thymus- 
derived cells of young NZB/NZW mice (11-14). The possibility remains that this 
evidence in favor of loss of T-cell suppressors could also be explained by assum- 
ing  that  NZB/NZW  animals  acquire  progressively increasing helper  T-cell 
function as they age which can be diluted by the addition of young NZB/NZW T 
cells to the system under study. Alternatively, the B cells from the NZB/NZW 
animals might be unresponsive to the negative signals produced by suppressor T 
cells. Finally, the view that there is a reduction in suppressor cells in NZB/NZW 
mice has recently been challenged by Roder et al.  (15) who have reported that 
the number of suppressor cells in the spleens of NZB/NZW mice increase rather 
than decrease as the animals age. 
To approach the question of T-cell  suppressor function in NZB/NZW mice 
more directly, we have taken advantage of the observations of Dutton (16, 17) 
and Rich and Pierce (18, 19) that splenic T cells can be activated by Cancana- 
valin A (Con A)  1  to become cells which suppress the immunological functions of 
other cells.  Furthermore, Rich  and Pierce (20, 21)  have shown that Con A- 
activated cells produce a soluble immune response suppressor (SIRS) which is 
suppressive to a  range of immune responses in vitro.  On the basis of these 
studies it becomes possible to measure T-cell suppressor function by studying 
the ability of Con A-activated cells and their supernate (SIRS), derived from a 
variety of sources, to inhibit defined immune responses in vitro. In the present 
1  Abbreviations  used  in this paper:  Con A, concanavalin A; PWM, pokeweed mitogen; SIRS, 
soluble immune response repressor. 
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investigation,  we  have  utilized  this  system  to  ask  two  questions  concerning 
NZB/NZW mice: (a) whether these animals have normal numbers of precursors 
of suppressor T cells that can be activated to become suppressors by Con A, and 
(b) whether the B cells from these animals can respond to negative suppressor 
signals from Con A-activated normal cells. 
Materials and Methods 
Animals.  Female NZB/NZW (NZB female x  NZW male matings), BALB/c, and C57BL/6 mice 
were obtained from colonies maintained at the National Institutes of Health, Bethesda, Maryland. 
In Vitro Biosynthesis oflgM.  To study the terminal differentiation of splenic B cells into IgM- 
producing plasma cells, exhaustively washed cells were cultured in vitro in the presence of the B- 
cell mitogen, pokeweed mitogen (PWM). The IgM produced and secreted by such cells during 7 
days of culture was then measured by a sensitive radioimmunoassay technique specific for IgM. In 
this technique, splenocytes were asceptically obtained from the appropriate animals, washed four 
times by centrifugation through fetal  calf serum,  and  cultured  in the presence  of PWM  at  a 
concentration of 2  x  106 splenocytes/ml; the culture was carried out at 37°C in 5% CO2 in loosely 
capped culture plates containing RPMI 1640 medium (Media Unit, National Institutes of Health, 
Bethesda, Md.) supplemented with glutamine, penicillin, streptomycin, and 10% heat-inactivated 
fetal calf serum (total culture volume: 1.1 ml). PWM (Grand Island Biological Co., Grand Island, 
N. Y.) was used at a concentration of 10 Mml. At the termination of the culture, the tubes were 
centrifuged and the amount of IgM synthesized and secreted into the culture medium was de- 
termined by double antibody radioimmunoassay of IgM.  Techniques for producing the antisera 
and defining the specificity and accuracy of the radioimmunoassay test were essentially identical 
to those previously described for a double antibody radioimmunoassay of IgE (22). In these assays, 
rabbits immunized with purified IgM derived from the serum of mice bearing the MOPC-104E 
tumor were the source of anti-IgM, radiolabeled mouse IgM (MOPC-104E) served as the labeled 
ligand, and whole mouse serum containing defined amounts of mouse IgM was used as the stand- 
ard. The IgM was purified from the serum by a combination of block electrophoresis and chroma- 
tography with Sephadex G-200. Rabbits were immunized with the purified IgM, and the antisera 
were made specific by absorption with Sepharose bound to mouse IgG. The antiserum used was 
shown to be monospecific by Ouchterlony analysis and by the demonstration that it bound radio- 
labeled mouse IgM but not mouse IgG~, IgG2,  and IgA. 
Preparation of Purified T- and B-CeU Populations from Mouse Spleens.  Purified T cells were 
prepared by the use of anti-Fab Sephadex G-200 immunoabsorbents using a  modification of the 
method of Chess et al.  (23).  The T-cell enriched populations obtained were in the nonadherent 
fraction, whereas the B-cell enriched populations were in the adherent fraction that was released 
from the column by the addition of mouse IgG.  The T-cell populations thus obtained did not 
undergo proliferation in response to lypopolysaccharide but did proliferate in response to phytohe- 
magglutinin  P  and  Con  A.  On  the  other hand,  B-cell  enriched  fractions  were  responsive  to 
lipopelysaccharide but not to  Con  A;  in this case  the  response to phytohemagglutinin P  was 
reduced by 80%. 
B-cell enriched populations were also obtained by treatment of whole spleen cell populations 
with mouse anti-O (Litton Bionetics Laboratory Products,  Kensington, Md.) serum and comple- 
ment. Again, the resultant cells were responsive to lipopolysaccharide but not to Con A. 
Production of Con A-Activated Cell Populations and SIRS.  Con A-activated suppressor cells 
were obtained by a  modification of the methods of Dutton (16,  17) and Rich and Pierce (18,  19). 
Specifically, mouse splenocytes at a  concentration of 2  ×  106/ml were cultured in 1-ml aliquots in 
the presence of tritiated 6  ×  crystallized Con A, 2 ~g/ml (Elscint Inc., Palisades Park, N. J.) for 
24 h. At the end of this period the cells were washed three times in balanced salt solution to remove 
the Con A. From the amount of remaining tritium counts in the washed cell suspension, it was 
determined that 98.5% of all Con A was washed out by this procedure. In separate studies it was 
found  that  this  amount  of residual  Con  A  was  not  mitogenic  and  could  not  suppress  IgM 
biosynthesis. 
SIRS was produced by taking the supernate of the cells cultured for 24 h in 2% fetal calf serum 
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Again,  Con  A  removal  was  estimated  from  the  amount  of tritium  counts  remaining  in  the 
supernate after absorption, and again it was found that 98.5% of all Con A had been removed by 
the absorption procedure. Here too it was shown that residual Con A in the supernate derived from 
activated cells is not mitogenic and is incapable of producing suppression of IgM biosynthesis in 
vitro. 
Results 
PWM-Induced IgM Biosynthesis  by Spleen Cells.  Spleen cells from normal 
BALB/c mice cultured in the presence of PWM synthesized 860+_120 ng of IgM/2 
x  106  cells in culture during a  7-day period.  Similar synthetic values were 
obtained from cells derived from C57BL/6 and from NZB/NZW mice of various 
ages (Fig.  1). The synthesis of IgM by spleen cells of adult NZB/NZW mice (18 
wk) was slightly greater (P  =  0.5) than that of young NZB/NZW mice (4 wk) 
(1,050_+140 ng vs.  770_+130 ng/2  x  106 cells).  An analysis of the time course of 
synthesis  and  release  of immunoglobulin molecules by  spleen cells  in  the 
presence of PWM indicated there was little synthesis and release of immuno- 
globulin during the first 3 or 4 days of culture. However, after this time the 
concentration of IgM in the culture medium increased rapidly with most of the 
synthesis occurring on the 6th  and  7th  days of culture.  The IgM  synthetic 
process could be at least 90% inhibited by irradiation of the cells with 2,000 R or 
by  the  addition  of puromycin (5  x  10  -4  M),  actinomycin D  (20  tLg/ml), or 
mitomycin C (25 t~g/ml) to the culture medium. In addition, relatively little IgM 
was produced when the cells were cultured in the absence of PWM  (mean: 
120_+80 ng/2  x  106 cells in culture). These studies indicate that the IgM mea- 
sured in the supernatant fluid is the result of the differentiation  of B cells into Ig 
synthesizing and secreting plasma cells rather than the result of release of IgM 
from pre-existing plasma cells in the spleen cell population. 
Effect  of Con  A  on  PWM-Induced IgM Biosynthesis  by  Mouse  Spleno- 
cytes. The addition of 2  t~g/ml of Con A to BALB/c  splenocyte cultures with 
PWM caused a 94% suppression of IgM synthesis by these cultures (Fig. 1). The 
addition  of Con  A  caused  a  comparable suppression  of PWM-induced IgM 
synthesis by C75BL/6 spleen cells  (95% inhibition)  and by splenocytes (85% 
inhibition) derived from young (4 wk) NZB/NZW mice. In contrast, Con A at 
this concentration caused significantly less (P < 0.001) suppression (27%) of  IgM 
synthesis by adult (18 wk) NZB/NZW mice. This result suggested that cultures 
from adult  BALB/c,  young and  adult C57BL/6, and young NZB/NZW mice 
contain cells which can be activated by Con A to become suppressor cells and 
that such precursors of suppressor cells are markedly diminished in adult NZB/ 
NZW mice. 
Suppressor  Effect  of Con A-Pulsed Spleen  Cells on PWM-Stimulated IgM 
Biosynthesis.  To  further investigate the  suppressor T-cell  activity of adult 
NZB/NZW mice and of normal mice, the cells from the spleens of various strains 
of mice were pulsed with Con A for 24 h and then washed to remove the Con A. 
The resultant Con A-pulsed cells were then co-cultured with equal numbers of 
previously untreated spleen cells from mice in the presence of PWM, and the 
IgM synthesis of  the resultant co-cultures was measured. As shown in Fig. 2 and 
Table I, Con A-pulsed splenocytes derived from BALB/c or C57BL/6 mice led to 
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BALB/c  C57BL/6  NZB/W  F~  NZB/W  F1 
AGE 4 WK  AGE 18 WK 
PWM-stimulated IgM synthesis of various mouse strains with and without 2/~g/ 
ml Con A. 
c or C57BL/6 splenocytes. In connection with these studies,  a  series of control 
experiments were performed to exclude the possibility that sufficient Con A was 
carried over with pulsed cells to inhibit the PWM-stimulated target cells. It was 
shown that  splenocytes mixed  with  Con A  and  washed  immediately  did not 
significantly  suppress the  PWM-induced IgM synthesis of co-cultured spleno- 
cytes (P >  0.3). Similarly, when Con A was added directly to PWM-stimulated 
splenocytes at a  concentration calculated to be present in the washed Con A- 
pulsed cells, there was no significant suppression of IgM biosynthesis (P >  0.4). 
The concentration of residual Con A after washing was determined in all cases 
using tritiated  Con A  as indicated in the Materials and Methods section.  The 
Con A-induced  suppressor cells were shown to be T  cells in  accord with the 
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C57BL/6  NZB/'W 
CELLS PULSED WITH CON A 
FIe.  2.  Percentage  suppression  (reading  down)  of  PWM-stimulated  IgM  synthesis  of 
BALB/c responders co-cultured with Con A-pulsed splenocytes of various mouse strains at 
various ages. 
TABLE  I 




BALB/c  C57BL/6  Young NZB/NZW  NZW 
BALB/c  84+-5  91-+8  83-+5  89-+5 
Young C57BL/6  86_+4  -  88_+7  90-+4 
Adult C57BL/6  92-+3  -  82-+4  78_+ 12 
Young NZB/NZW  82_+14  91-+8  80_+10  80-+10 
Adult NZB/NZW  10+- 18  20-+ 15  -6-+ 14  2_+ 14 
found that anti-0 treatment  of the spleen cells before exposure to Con A  com- 
pletely abrogated the suppressor activity of the BALB/c cells (Fig. 3). In another 
approach, spleen cell populations were fractionated by anti-Fab Sephadex G-200 
columns, and the resultant T- and B-cell fractions were then pulsed with Con A 
and tested for suppressor activity in co-culture studies. It was found that the T- 
cell fraction and not the B-cell fraction was suppressive. 
Loss of Suppressor  Capacity by Con A-Pulsed Spleen Cells with Age in NZB / 
NZW Mice.  The ability of spleen cells from NZB/NZW animals to be activated 
to become suppressor cells after pulsing with Con A for 24 h was then examined. 
The Con A-pulsed spleen cells from young (4 wk) NZB/NZW mice caused a level 
of suppression of IgM synthesis by spleen cells from a variety of sources that was 
comparable to that  seen when  Con A-pulsed spleen cells were obtained from 
BALB/c or C57BL/6 strains  (Fig.  2, Table I). In contrast,  Con A-pulsed spleen 
cells from adult (18 wk) NZB/NZW mice lacked significant suppressor activity 
(P  =  0.25).  We conclude that NZB/NZW mice lose suppressor cell activity as 
they age.  This age-dependent loss of Con A  suppressor T-cell activity is not a 
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Adherent 
Fro.  3.  Percentage  suppression  (reading  down)  of PWM-stimulated  IgM  synthesis  of 
BALB/c responders co-cultured with Con A-pulsed BALB/c splenocytes, anti-8 and comple- 
ment  (C)-treated  splenocytes,  and  splenocytes  separated  on  an  antimouse  Fab  affinity 
column. 
cytes derived from both young and adult C57BL/6 mice could be induced by 
incubation with Con A to form suppressor cell populations (Fig. 2, Table I). It 
should be noted that even though adult NZB/NZW mice splenocytes cannot be 
induced to form suppressor cells by incubation with Con A, such NZB/NZW 
splenocytes have proliferative responses induced by this dose of mitogen (2 fig/ 
ml) that were not significantly different from the normal (P =  0.2). 
The Production  of SIRS by Con A-Activated Spleen Cells from Normal Mice 
Strains and from Young and Old NZB/NZW Mice.  Supernatant fluids from 
Con A-activated spleen cells have previously been shown to be potent suppres- 
sors of antibody synthesis (20). We therefore investigated the ability of spleen 
cells from normal mice and from NZB/NZW mice to produce SIRS  for IgM 
biosynthesis following Con A stimulation. Con A was removed from the super- 
natant fluid by absorption with Sephadex G-75. When 5 ftl of the supernatant 
fluids from Con A-activated spleen cells of BALB/c or C57BL/6 mice was added 
to  1-ml  cultures of spleen cells of a  variety of sources,  IgM  synthesis was 
inhibited by 79-81% in all cultures tested (Fig.  4,  Table II).  This amount of 
supernatant fluid (5 k) from Con A-activated spleen cells of young NZB/NZW 
mice added to PWM-stimulated cultures was similarly inhibitory with a  sup- 
pression of 72_+16%. In contrast, the supernatant fluids derived from Con A- 
pulsed adult NZB/NZW spleen cells failed to significantly inhibit IgM synthesis 
by cultures of autologous spleen cells (inhibition 14_+20%, P  > 0.3). We conclude 
that the adult NZB/NZW mice spleen produced less active SIRS than normal 
spleen cells or the spleen cells of young NZB/NZW mice. Thus, NZB/NZW mice 
appear to lose precursors of Con A-activatable suppressor T cells and the ability 
to produce the T-cell suppressor humoral product (SIRS) as they age. 
Ability  of Spleen  Cells  from  NZB/NZW  Mice  to  Respond  to  Suppressor 
Signals.  The ability of PWM-simulated spleen cells from young and adult 668  LOSS  OF  SUPPRESSOR  T  CELLS  IN  ADULT  NZB/NZW  MICE 
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BALB/c C57BL/6 Young  Adult 
NZB/W  NZB/W 
Fro.  4.  Percentage  suppression  (reading  down)  of PWM-stimulated IgM  synthesis of 
BALB/c responders with SIRS from Con  A-stimulated splenocytes of the strains listed 
above (final SIRS concentration 1:200). 
TABLE  II 
Suppression  of IgM Synthesis of Various Responding Cells Induced by SIRS from 
Various  Murine Sources (Final SIRS Concentration  = 1:200) 
Sources of sirs 
Responding cells 
BALB/c  Young NZB/NZW  Adult NZB/NZW 
BALB/c  81-2_ 19  84-+ 18  80_ 14 
C57BL/6  79-+ 16  -  - 
Young NZB/NZW  72-+ 16  74 ± 22  72 ± 20 
Adult NZB/NZW  14_+20  14_+20  8_+24 
NZB/NZW mice to be inhibited by suppressor signals was then investigated. It 
was demonstrated (Fig. 5, Tables I and II) that both young and adult NZB/NZW 
spleen  cells stimulated  with  PWM  could be  suppressed by  Con  A-activated 
spleen cells from BALB/c,  C57BL/6,  or young NZB/NZW animals.  The IgM 
production of PWM-stimulated spleen cells from the young and adult NZB/NZW 
mice could also be suppressed by supernates of Con A-activated spleen cells 
(SIRS) from normal strains or from young NZB/NZW mice (Fig. 4).  Thus.  al- 
though adult NZB/NZW mice lose suppressor T-cell activity as they age, these 
cells are still responsive to the normal regulatory suppressor signals provided by 
Con A-activated T cells or their products. 
Discussion 
The  concept  that  autoimmunity in  NZB/NZW  mice  is  related  to  loss  of 
suppressor T-cell activity has been supported in the past by a  variety of data 
that bear indirectly on the question of suppressor T-cell function. In the most 
compelling studies, beth humoral and cellular immune responses were shown to 







100  BALB/c  Young NZB/W  Adult  NZB/W 
FIo.  5.  Percentage suppression (reading down) of PWM-stimulated IgM synthesis of adult 
(18 wk) NZB/W responders with SIRS from Con A-stimulated splenocytes of the strains 
listed above (final SIRS concentration 1:200).  Note adult NZB/W mice respond to suppres- 
sion by SIRS from BALB/c and young NZB/W animals even though they do not themselves 
mediate suppression. 
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with the responses at 10-26 wk of age (5, 12, 14, 24). Thus, NZB/NZW antibody 
responses  to  the thymic-independent antigens,  pneumococcal polysaccharide 
and poly I-C,  increased (4,  12,  14)  and,  in addition,  the ability of NZB/NZW 
spleen cells to mediate graft vs.  host reactions in appropriate recipients was 
enhanced as NZB/NZW animals aged (7,  11,  13). In both cases this increased 
response with age was abrogated by the injection of thymocytes obtained from 
the young NZB animals into the adult NZB animals under study. These data are 
most easily interpreted by assuming that suppressor cell activity in NZB/NZW 
animals  declines with  age  and  that  the addition  of thymocytes from young 
animals replenishes suppressor cell activity. However, an alternative explana- 
tion is that the enhanced responses are due to activation of helper T-cell activity 
with age, and the helper T cells can be competitively inhibited by the addition of 
young thymocytes not yet activated by the disease process. 
The  results  obtained  in  the  present  studies  provide  direct  evidence  that 
suppressor cell function in NZB/NZW mice is in fact lost as such animals age. In 
these studies we utilize a  direct test of suppressor-cell function, the ability of 
Con A-activated cells to mediate immunosuppression, to study suppressor cell 
activity in  NZB/NZW mice.  We found that  young NZB/NZW  animals  have 
normal suppressor activity, as judged by the ability of Con A-activated spleen 
cells from young animals to inhibit PWM-driven IgM biosythesis in vitro.  In 
contrast, adult NZB/NZW mice have reduced suppressor activity, as judged by 
the inability of Con A-activated cells from adult animals to inhibit PWM-driven 
IgM biosynthesis in vitro. Parallel with the work of Dutton (16, 17) and Rich and 
Pierce (18,  19),  the suppressor cells under study were shown in these experi- 
ments to be T cells. In addition, the suppression could be mediated by a  solube 
material  (SIRS) present in  the supernatant fluid of Con A-activated normal 
spleen  cells.  As  one  would  expect  from  the  data  on  Con  A-activated  cells 
themselves,  the  inhibitory  potential  of SIRS  derived from  Con  A-activated 
spleen cells of young NZB/NZW mice was similar to that of supernates of Con A- 670  LOSS  OF  SUPPRESSOR  T  CELLS  IN  ADULT  NZB]NZW  MICE 
pulsed cells obtained from other mouse strains, whereas the inhibitory potential 
of SIRS obtained from adult NZB/NZW mice had markedly reduced inhibitory 
activity.  These  studies with supernatant  suppressor material,  therefore,  con- 
firm the fact that adult NZB/NZW mice have reduced suppressor T-cell activity. 
Although  the  adult  NZB/NZW mice  lose the  precursors  of cells  that  can be 
activated to become suppressors by Con A, they are still normally responsive to 
negative signals in that their PWM-driven IgM b~osynthesis could be inhibited 
by co-culturing cells obtained from adult animals with Con A-activated T cells 
or with SIRS from normal animals. 
The occurrence of an abnormality in suppressor T-cell function in NZB/NZW 
mice  suggests  that  a  similar  phenomenon  may  be  characteristic  of human 
systemic  lupus  erythematosus  and  other  human  conditions  associated  with 
autoimmunity. Such a finding would be complementary to our previous observa- 
tion that a  subset of patients with common variable hypogammaglobulinemia 
demonstrate  excessive T-cell  activity and that  at least in some instances this 
may be the basis of the hypogammaglobulinemia (25). The findings in hypogam- 
maglobulinemia are based on studies parallel to those reported here in that in 
both instances PWM-driven immunoglobulin  synthesis is studied in the pres- 
ence or absence of cells whose suppressor capability is being tested. In the case of 
some of the patients with hypogammaglobulinemia,  un~timulated peripheral T 
cells  were  found  to  suppress  immunoglobulin  production  by  normal  cells, 
whereas normal peripheral T cells did not suppress immunoglobulin production. 
In the case of adult NZB/NZW mice, Con A-activated spleen cells were found to 
lack suppressor activity that is normally present.  Thus,  NZB/NZW mice and 
hypogammaglobulinemic  patients  represent  two ends  of a  spectrum  of T-cell 
regulatory defects. 
A major question yet to be answered is whether the loss of suppressor T-cell 
activity is the  primary  event in  the  autoimmune  phenomenon  of NZB/NZW 
animals or whether it is a secondary event related to infection of these animals 
with viruses or to the development of natural antithymocyte antibodies. In favor 
of the idea that loss of suppressor T cells is the primary event is the fact that 
NZB/NZW mice have a  hyperresponsiveness to sheep erythrocytes within the 
first 10 days of life (5). Since the natural antithymocyte antibody found in NZB/ 
NZW mice is an IgM antibody (8) that is not transferred to the fetus, one would 
not expect to have an effect of such an antibody so early in life. In addition, the 
loss of suppressor cells in NZB/NZW mice occurs between 3 and 10 wk of age 
before significant titers of natural antithymocyte antibody appear (7). Whatever 
the  cause of suppressor  T-cell  activity  loss in  NZB/NZW mice,  it  is easy to 
suppose  that  suppressor  T  cells  usually  play  an  important  role  in  negative 
feedback of antibody responses and  that  loss of suppressor T  cells results  in 
autoantibody formation with the consequent development of Coombs' positive 
hemolytic  anemia,  immune  complex  nephritis,  and  other  manifestations  of 
autoimmune disease. In this sense, if loss of suppressor T cells is not the primary 
event in NZB/NZW autoimmunity,  it is at least a proximal event in a  chain of 
causation. 
To date  the  suggestion that  NZB/NZW mice  have  a  reduction  of negative 
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augment the capacity of these animals to produce suppressor signals. One such 
attempt  involves  the  use  of thymosin and  is  related to  the  observation of 
Dauphinee and Talal (26) that both NZB/NZW thymosin levels and the prolifer- 
ative response of NZB/NZW thymocytes  in allogeneic recipients decrease as the 
animals age. Dauphinee and Talal (26) found that thymosin does in fact correct 
the  proliferative  response  of older  NZB/NZW  thymocytes; however,  when 
Gershwin et al. (27) treated NZB/NZW mice with thymosin in various schedules 
starting at different ages, they did not observe a  dramatic delay in onset of 
autoimmunity.  In  another  attempt  to  augment  suppressor  T-cell  activity, 
Gershwin and Steinberg treated NZB/NZW mice in vivo  with Con A.  They 
observed that Con A treatment given to young mice does in fact result in a more 
prolonged tolerance to foreign protein antigens than in untreated mice, but 
nevertheless the animals lose tolerance at a time when normal animals main- 
tain tolerance (28). This relative failure of Con A treatment is in accord with the 
observations of the present studies wherein we show that there is progressive 
decline in the number of cells in the spleen of NZB/NZW animals that can be 
activated to become suppressor cells by Con A treatment. Finally, NZB/NZW 
autoimmunity has been treated by the administration of thymocytes  or spleno- 
cytes from young NZB/NZW mice. Such treatment inhibited the development of 
Coombs'  positive  hemolytic anemia but  was  only  marginally successful  in 
preventing other  autoimmune phenomena.  In  addition,  initiation  of young 
thymocyte treatment at 10 wk of age when the autoimmunity was becoming 
established rather than at 4 wk of age was ineffective (11, 13). This may be due 
to the relatively early development in NZB/NZW animals of cytotoxic natural 
antithymocyte antibodies that destroy the transferred T cells. 
The demonstration in this study of a  soluble suppressor substance derived 
from T cells by Con A stimulation (i.e., SIRS)  and the observation that adult 
NZB/NZW mice are  responsive to  this  negative signal  raise the  intriguing 
possibility of treating these mice and, by extension, of treating humans with 
systemic lupus erythematosus in a more physiological manner with this soluble 
suppressor protein. Indeed, in preliminary studies, the administration of SIRS 
to NZB/NZW animals from an early age led to the development of hypogamma- 
globulinemia in these animals as well as a marked delay and reduction in extent 
of the development of anti-DNA antibody, Coombs' positive hemolytic anemia, 
and immune complex nephritis. 
Summary 
We have investigated suppressor T-cell activity in female NZB/NZW FI mice 
using PWM-driven IgM biosynthesis in vitro as an indicater system. In initial 
studies we observed that spleen cells from normal mice (BALB/c, C57BL/6), as 
well as from young (4 wk) and adult (18 wk) NZB/NZW mice, cultured in the 
presence of PWM synthesize 860_+120 ng IgM/10  ~ cells/7 days. However, when 
Con A (at 2 ~g/ml) was added directly to the cultures (along with PWM), cells 
obtained from adult normal mice and young NZB/NZW mice showed a  94% 
suppression of IgM synthesis, whereas cells obtained from adult NZB/NZW mice 
were suppressed significantly less. 
To analyze these findings we studied the effect of Con A-induced suppressor 672  LOSS  OF  SUPPRESSOR  T  CELLS  IN  ADULT  NZB/NZW  MICE 
cells (cells cultured with Con A for 24 h  and washed free of Con A) on PWM- 
driven IgM biosynthesis. Spleen cells obtained from normal mice cultured in the 
presence of Con A-pulsed cells obtained from normal mice and young NZB/NZW 
mice showed an 83-88%  suppression of PWM-driven IgM synthesis. Similarly, 
supernates obtained from Con A-pulsed cells of normal mice or of young NZB/ 
NZW mice suppressed PWM-driven IgM synthesis. This suppression by Con A- 
pulsed cells and their supernates required T cells since T-cell fractions but not B- 
cell fractions eluted from anti-Fab Sephadex columns mediated suppression of 
co-cultured normal cells; in addition, Con A-pulsed cells treated with anti-0 and 
complement do not mediate suppression. These studies of Con A-induced sup- 
pressor cell activity in normal mice and young NZB/NZW mice contrast with 
studies of Con A-induced suppressor cell activity in adult NZB/NZW mice. We 
found that adult NZB/NZW Con A-pulsed cells and supernates obtained from 
such Con A-pulsed cells had vastly decreased suppressor potential; in this case 
the Con A-pulsed cells and supernatant fluids derived from such cells did not 
suppress PWM-driven IgM synthesis by normal cells. Finally, whereas spleen 
cells  from  young and  adult  NZB/NZW  mice  differ in  their  suppressor  cell 
potential, cells from both sources could respond equally to suppressor signals in 
that Con A-pulsed normal cells or supernates derived from such cells caused 
equivalent suppression of PWM-driven IgM synthesis by young and adult NZB/ 
NZW cells. These observations allow us to conclude that NZB/NZW mice lose 
suppressor T-cell activity as they age. 
Received for publication 17 May 1976. 
References 
1.  Playfair, J. H. 1971. Strain differences in the immune responses of mice. III. A rasied 
tolerance threshold in NZB thymus cells. Immunology.  21:1037. 
2.  Staples,  P. J., A. D. Steinberg,  and N. Talal.  1970. Induction of tolerance  in older 
New Zealand mice repopulated with young spleen, bone marrow or thymus. J. Exp. 
Med.  131:1223. 
3.  Allison, A. C. 1974. Interaction ofT and B lymphocytes in self-tolerance and autoim- 
munity. In Immunological Tolerance: Mechanisms and Potential Therapeutic Appli- 
cations. D. H. Katz and B. Benacerraf, editors. Academic Press, Inc., New York. 25- 
59. 
4.  Chused, T. M., A. D. Steinberg,  and L. M. Parker. 1973. Enhanced antibody response 
of  mice to polyinosinic polycytidylic acid by antithymocyte  serum and its age depend- 
ent loss in NZl~/W mice. J. Immunol.  111:52. 
5.  Talal, N.,  and A. D.  Steinberg.  1974. The pathogenesis  of autoimmunity in New 
Zealand black mice. In Current Topics in Microbiology and Immunology. Springer- 
Verlag Publishers,  Berlin. 
6.  Steinberg,  A. D. 1974. Pathogenesis of autoimmunity in New Zealand mice. V. Loss 
of thymic suppressor function. Arthritis Rheum.  17:11. 
7.  Gelfand,  M. S.,  L. M. Parker, and A. D.  Steinberg.  1974. Mechanism  of allograft 
rejection in New Zealand mice. II. Role of a serum factor. J. Immunol.  113:1. 
8.  Parker, L. M., T. M. Chused, and A. D. Steinberg.  1974. Immunofluorescence studies 
on thymocytotexic antibody from New Zealand Black mice. J. Immunol.  112:285. 
9.  Gerber, N. L., J. A. Hardin, T. M. Chused, and A. D. Steinberg.  1974. Loss with age 
in NZB/W mice of thymic suppressor  cells in the graft versus  host reaction.  J. 
Immunol.  113:1618. R.  S.  KRAKAUER,  T.  A.  WALDMANN,  AND  W.  STROBER  673 
10.  Allison, A. C., A. M. Denman, and R. D. Barnes. 1971. Cooperating and controlling 
functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 2:135. 
11.  Kysela,  S.,  and  A.  D.  Steinberg.  1973. Increased survival of NZB/W  mice given 
multiple syngeneic young thymus grafts. Clin. Immunol. Immunopathol.  2:133. 
12.  Barthold,  D. R., S.  Kysela, and A. D. Steinberg.  1974. Decline in suppressor T cell 
function with age in female NZB mice. J. Immunol.  112:9. 
13.  Gelfand, M. C., and A. D. Steinberg. 1973. Mechanism of allograft rejection in New 
Zealand mice. I. Cell synergy and its age dependent loss. J. Immunol.  110:1652. 
14.  Barthold, D. R., B. Prescott, P. W. Stashak, D. F. Amsbaugh and P. J. Baker. 1974. 
Regulation of the  antibody response to type III pneumococcal polysaccharide.  III. 
Role of regulatory T cells in the development of an IgG and IgA antibody response. J. 
Immunol.  112:1042. 
15.  Roder, J. C., D. A. Bell, and S. K. Singhal.  1975. Suppressor cells in New Zealand 
mice:  possible  role  in  the  generation  of autoimmunity.  In  Suppressor  Cells  in 
Immunity. S. K. Singhal and N. R. Sinclair, editors. University of Western Ontario, 
London, Canada. 
16.  Dutton,  R.  W.  1972. Inhibitory and stimulatory effects of Concanavalin A  on the 
response  of mouse  spleen cell  suspensions  to  antigen.  I.  Characterization  of the 
inhibitory cell activity. J. Exp. Med.  136:1445. 
17.  Dutton,  R.  W.  1973. Inhibitory and stimulatory effects of Concanavalin A  on the 
response  of mouse  spleen  cell  suspensions  to  antigen.  II.  Evidence  for  separate 
stimulatory and inhibitory cells. J. Exp. Med.  138:1496. 
18.  Rich, R. R., and C. W. Pierce. 1973. Biological expressions of lymphocyte activation. 
I. Effects of phytomitogens on antibody synthesis in vitro. J. Exp. Meal.  137:205. 
19.  Rich, R. R., and C. W. Pierce. 1973. Biological expressions of lymphocyte activation. 
II. Generation of a  population of thymus-derived suppressor lymphocytes. J. Exp. 
IVied. 137:649. 
20.  Rich, R. R., and C. W. Pierce. 1974. Biological expressions of lymphocyte activation. 
III. Suppression of plaque-forming cell responses in vitro by supernatant fluids from 
Concanavalin A-activated spleen cell cultures. J. Immunol.  112:1360. 
21.  Rich, R. R., and S. H. Rich. 1975. Biological expressions of lymphocyte activation. IV. 
Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions. J. 
Immunol.  114:1112. 
22.  Waldmann, T. A., S. H. Polmar, S. T. Balestra, M. C. Jost, R. M. Bruce, and W. D. 
Terry. 1972. Double antibody radioimmunoassay for IgE. J. Immunol.  109:304. 
23.  Chess, L., R. P. MacDermott, and S. F. Schlossman. 1974. Immunologic functions of 
isolated human lymphocyte subpopulations. J. Immunol.  113:1113. 
24.  Niaudet,  P.,  and M.  A.  Bach.  1976. Thymic function in NZB mice. I. Duration of 
thymic function in New Zealand black (NZB) mice. Clin. Exp. Immunol.  23:328. 
25.  Waldmann, T. A., S.  Broder, R. Krakauer, M.  Durm, C. Goldman, and B. Meade. 
1975. The role ofT-cells in immunodeficiency. In Suppressor Cells in Immunity. S. K. 
Singhal and N. R. Sinclair, editors. University of Western Ontario, London, Canada. 
182-188. 
26.  Dauphinee, M. J., N. Talal, A. L. Goldstein, and A. White. 1974. Thymosin corrects 
the abnormal DNA synthetic response of NZB mouse thymocytes. Proc. Natl. Acad. 
Sci. U.S.A.  71:2637. 
27.  Gershwin, M. E., A. Ahmed, A. D. Steinberg, G. B. Thurman, and A. L. Goldstein. 
1974. Correction of T cell function by thymosin in New Zealand mice. J. Immunol. 
113:1068. 
28.  Gershwin, M. E., and A. D. Steinberg. 1975. Effects of Concanavalin A on immuno- 
logic abnormalities of New Zealand (NZB/W) mice. Int. Arch. Allergy Appl. Immu- 
nol.  48:220. 